--- title: "Resona Holdings (TSE:8308) Lifts Guidance And Launches Buyback, Is The Stock Too Pricey?" type: "News" locale: "en" url: "https://longbridge.com/en/news/294713220.md" description: "Resona Holdings (TSE:8308) announced a share repurchase program of up to 30 billion yen and updated earnings guidance. Despite a recent 7.36% price drop, the stock has gained 41.07% year-to-date. Valuation views are split: one narrative suggests the stock is overvalued at ¥2,191.5 against a fair value of ¥1,334.76 due to demographic headwinds, while an SWS DCF model estimates a higher fair value of ¥3,487.5." datetime: "2026-08-03T15:19:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294713220.md) - [en](https://longbridge.com/en/news/294713220.md) - [zh-HK](https://longbridge.com/zh-HK/news/294713220.md) generator: "portal-rs" --- # Resona Holdings (TSE:8308) Lifts Guidance And Launches Buyback, Is The Stock Too Pricey? Resona Holdings (TSE:8308) has put fresh focus on its stock after announcing a share repurchase program of up to 30,000,000 shares for ¥50,000 million, alongside updated earnings guidance and first quarter results. See our latest analysis for Resona Holdings. Despite the recent 7 day share price return declining 7.36% to ¥2,191.5, Resona Holdings still shows strong momentum, with a year to date share price return of 41.07% and a very large 5 year total shareholder return of 498.71%. If this kind of renewed interest has you looking beyond Resona Holdings, it could be a good time to see what else is moving and uncover 10 top founder-led companies After a strong multiyear run and a fresh buyback on the table, Resona Holdings is not an obvious bargain or a clear sell-off candidate. Does the risk-reward still lean in favour of new buyers at this price? ## Most Popular Narrative: 64.2% Overvalued Based on the most followed narrative, Resona Holdings has a fair value of ¥1,334.76 compared with the last close of ¥2,191.5, which implies a wide gap that this view aims to explain in detail. > *Japan faces a persistent demographic decline as its population continues to age and shrink, which is expected to erode the customer base and suppress long-term loan demand for Resona Holdings, leading to structurally lower revenue growth and putting pressure on net interest income in coming years.* *Read the complete narrative.* Read the complete narrative. The heart of this narrative is simple. It highlights slower top line, fatter margins, and a very different earnings mix in a few years. Want to see which revenue expectations, margin profile, and future valuation multiple have been combined to arrive at that ¥1,334.76 figure, and how they compare with the current analyst spread? **Result: Fair Value of ¥1,334.76 (OVERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, Resona Holdings could surprise if its digital reforms start to cut costs faster than expected and if the planned alliance with JR West lifts fee income resilience. Find out about the key risks to this Resona Holdings narrative. ## Another View on Resona Holdings Valuation The overvaluation narrative leans heavily on bearish analyst targets, yet the SWS DCF model points in the opposite direction. On that approach, Resona Holdings at ¥2,191.5 is trading at a discount to an estimated future cash flow value of ¥3,487.5, which suggests a very different risk picture. Which story do you think best aligns with your expectations for the bank's cash generation? Look into how the SWS DCF model arrives at its fair value. 8308 Discounted Cash Flow as at Aug 2026 ## Next Steps The split views around Resona Holdings highlight that the story is not one-sided, so it makes sense to act promptly and check the data yourself. To weigh up the concerns alongside the potential upside in one place, take a closer look at the 3 key rewards and 1 important warning sign ## Looking for more investment ideas beyond Resona Holdings? Resona Holdings may sit at the centre of your watchlist today, but some of the most interesting opportunities often sit just off the radar. - Target cash generative businesses trading below their estimated worth by reviewing 19 high quality undervalued stocks that pair quality fundamentals with appealing price tags. - Strengthen your income stream by scanning 42 dividend fortresses that focus on higher yielding payouts with support from underlying cash flows. - Prioritise capital protection by checking 58 resilient stocks with low risk scores that score well on resilience and financial stability. *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.* ### **New:** AI Stock Screener & Alerts Our new AI Stock Screener scans the market every day to uncover opportunities. • Dividend Powerhouses (3%+ Yield) • Undervalued Small Caps with Insider Buying • High growth Tech and AI Companies Or build your own from over 50 metrics. Explore Now for Free ### Related Stocks - [8308.JP](https://longbridge.com/en/quote/8308.JP.md) - [9021.JP](https://longbridge.com/en/quote/9021.JP.md) ## Related News & Research - [Resona Holdings launches share buyback of up to 30,000,000 shares worth JPY 50 billion](https://longbridge.com/en/news/294468323.md) - [Resona: Record 1Q profit, higher earnings target, and expanded shareholder returns on strong loan growth](https://longbridge.com/en/news/294468482.md) - [The Calmer Co. Details ASX Governance Compliance in Appendix 4G Filing](https://longbridge.com/en/news/297454626.md) - [172,799 Shares in MarketAxess Holdings Inc. $MKTX Acquired by Freestone Grove Partners LP](https://longbridge.com/en/news/297285059.md) - [Financière de la Montagne, Valerio Therapeutics director, purchases EUR 7 million in shares](https://longbridge.com/en/news/297351610.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**